Ets-1 expression promotes epithelial cell transformation by inducing migration, invasion and anchorage-independent growth

Oncogene

Volumn 24, Issue 34, 2005, Pages 5384-5388

  Hahne, Jens Claus ^a   Okuducu, Ali Fuat ^a,c   Kaminski, Annette ^a   Florin, Alexandra ^a   Soncin, Fabrice ^b   Wernert, Nicolas ^a  

^a UNIVERSITY OF BONN   (Germany)

^b INSTITUT DE BIOLOGIE DE LILLE   (France)

^c HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Anchorage independent growth; Epithelial HeLa tumor cells; Ets 1; Invasion; Migration

Indexed keywords

BETA2 INTEGRIN; TRANSCRIPTION FACTOR ETS 1; ETS1 PROTEIN, HUMAN; ONCOPROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ETS;

ARTICLE; CELL ADHESION; CELL ANCHORAGE; CELL GROWTH; CELL INVASION; CELL MIGRATION; CELL TRANSFORMATION; CELL TYPE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; EPITHELIUM CELL; HELA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION; BIOSYNTHESIS; CANCER INVASION; CELL MOTION; CELL PROLIFERATION; DISEASE COURSE; GENETICS; PHENOTYPE; PHYSIOLOGY;

CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; EPITHELIAL CELLS; HELA CELLS; HUMANS; NEOPLASM INVASIVENESS; PHENOTYPE; PROTO-ONCOGENE PROTEIN C-ETS-1; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-ETS; TRANSCRIPTION FACTORS;

EID: 24044501934     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1208761     Document Type: Article

References (38)

1. Adam M, Schmidt D, Wardelmann E, Wernert N and Albers P. (2003). Eur. Urol., 44 ,329-336.
2. Adriaenssens E, Lottin S, Berteaux N, Hornez L, Fauquette W, Fafeur V, Peyrat JP, Le Bourhis X, Hondermarck H, Coll J, Dugimont T and Curgy JJ. (2002). Exp. Cell Res., 275 ,215-229.
3. Baker KM, Wei G, Schaffner AE and Ostrowski MC. (2003). J. Biol. Chem., 278, 17876-17884.
4. Behrens P, Mathiak M, Mangold E, Kirdorf S, Wellmann A, Fogt F, Rothe M, Florin A and Wernert N. (2003). Int. J. Cancer, 107, 183-188.
5. Behrens P, Rothe M, Wellmann A, Krischler J and Wernert N. (2001). J. Pathol., 194 ,43-50.
6. Block KL, Shou Y and Poncz M. (1996). Blood, 88, 2071-2080.
7. Bottinger EP, Shelley CS, Farokhzad OC and Arnaout MA. (1994). Mol. Cell. Biol., 14 ,2604-2615.
8. Bradford AP, Wasylyk C, Wasylyk B and Gutierrez-Hartmann A. (1997). Mol. Cell. Biol., 17, 1065-1074.
9. Danen EH and Yamada KM. (2001). J. Cell. Physiol., 189, 1-13.
10. Dittmer J. (2003). Mol. Cancer, 2, 29.
11. Fafeur V, Tulasne D, Queva C, Vercamer C, Dimster V, Mattot V, Stehelin D, Desbiens X and Vandenbunder B. (1997). Cell. Growth Differ., 8, 655-665.
12. Gilles C, Polette M, Birembaut P, Brunner N and Thompson EW. (1997). Clin. Exp. Metast., 15, 519-526.
13. Graham FL and van der Eb AJ. (1973). Virology, 52, 456-467.
14. Ishii Y, Ogura T, Tatemichi M, Fujisawa H, Otsuka F and Esumi H. (2003). Int. J. Cancer, 103, 161-168.
15. Kumar CC. (1998). Oncogene, 17, 1365-1373.
16. Liotta LA, Tryggvason K, Garbisa S, Hart I, Foltz CM and Shafie S. (1980). Nature, 284, 67-68.
17. Maubant S, Staedel C and Gauduchon P. (2002). Bull. Cancer, 89, 923-934.
18. Maurer P, T'Sas F, Coutte L, Callens N, Brenner C, Van Lint C, de Launoit Y and Baert JL. (2003). Oncogene, 22, 3319-3329.
19. Meraro D, Gleit-Kielmanowicz M, Hauser H and Levi BZ. (2002). J. Immunol., 168, 6224-6231.
20. Nishikawa A, Iwasaki M, Akutagawa N, Manase K, Yamashita S, Endo T and Kudo R. (2000). Gynecol. Oncol., 79, 256-263.
21. Paumelle R, Tulasne D, Kherrouche Z, Plaza S, Leroy C, Reveneau S, Vandenbunder B, Fafeur V and Tulashe D. (2002). Oncogene, 21, 2309-2319.
22. Paumelle R, Tulasne D, Leroy C, Coll J, Vandenbunder B and Fafeur V. (2000). Mol. Biol. Cell, 11, 3751-3763.
23. Peterson EJ. (2003). Immunol Rev., 192, 113-121.
24. Petrella A, Doti I, Agosti V, Giarrusso PC, Vitale D, Bond HM, Cuomo C, Tassone P, Franco B, Ballabio A, Venuta S and Morrone G. (1998). Blood, 91, 4554-4560.
25. Pourtier-Manzanedo A, Vercamer C, Van Belle E, Mattot V, Mouquet F and Vandenbunder B. (2003). Oncogene, 22, 1795-1806.
26. Ruoslahti E. (1991). J. Clin. Invest., 87, 1-5.
27. Sato Y. (1998). Hum. Cell., 11, 207-214.
28. Schwartz MA and Assoian RK. (2001). J. Cell. Sci., 114, 2553-2560.
29. Seth A and Papas TS. (1990). Oncogene, 5, 1761-1767.
30. Tajima A, Miyamoto Y, Kadowaki H and Hayashi M. (2000). Biochim. Biophys. Acta, 1492, 377-384.
31. Vandenbunder B, Pardanaud L, Jaffredo T, Mirabel MA and Stehelin D. (1989). Development, 107, 265-274.
32. Waga K, Nakamura Y, Maki K, Arai H, Yamagata T, Sasaki K, Kurokawa M, Hirai H and Mitani K. (2003). Oncogene, 22, 59-68.
33. Wasylyk B, Hahn SL and Giovane A. (1993). Eur. J. Biochem., 211, 7-18.
34. Wasylyk C, Schlumberger SE, Criqui-Filipe P and Wasylyk B. (2002). Mol. Cell. Biol., 22, 2687-2702.
35. Wernert N. (1997). Virchows Arch., 430, 433-443.
36. Wernert N, Gilles F, Fafeur V, Bouali F, Raes MB, Pyke C, Dupressoir T, Seitz G, Vandenbunder B and Stehelin D. (1994). Cancer Res., 54, 5683-5688.
37. Wernert N, Raes MB, Lassalle P, Dehouck MP, Gosselin B, Vandenbunder B and Stehelin D. (1992). Am. J. Pathol., 140, 119-127.
38. Wernert N, Stanjek A, Kiriakidis S, Hügel A, Jha HC, Mazitschek R and Giannis A. (1999). Angew. Chem., 38, 3228-3231.